Practice interviews

The buyer wants an AI demo. What would prove value?

A support director likes Quayline’s AI demo. Finance will not buy on a polished sample.

The question

You own the commercial trial. The buyer supplies 80 historical requests and can review a limited sample. All data is authored.

Invented Trial discussion
  • Support directorShow the tool answering our most common requests.
  • FinanceI need to know whether correct resolutions improve after human review.
  • OperationsWe can label a held-out set. An answer that invents a refund policy is unacceptable.
  • ITAn anonymized test set is available; live customer access is not approved.

“Define a buyer-owned trial outcome and a decision meeting. Do not promise a result you have not measured.”

A strong answer, step by step

Open each step in turn. This is one strong answer, not the only one.

Step 1: Choose the proof

What would you do here? Open the move you’d make.

  • Agree the buyer’s acceptance measure

    The strong move. A trial must answer the buyer’s decision question.

  • Use successful demo responses as the acceptance measure

    Tempting, but it misses something. Hand-picked fluent answers cannot establish a useful result.

See how a strong candidate says it

“I would agree correct, policy-supported resolutions after review as the primary measure. Finance and support must approve the definition and the comparison with current work.”

What a strong candidate could say

Why it works: A trial must answer the buyer’s decision question.

Step 2: Use unseen evidence

What would you do here? Open the move you’d make.

  • Use every supplied example to improve the trial

    Tempting, but it misses something. Reporting results on the same tuned examples hides overfitting.

  • Reserve an unseen test set

    The strong move. A held-out set prevents the demonstration from testing memorized examples.

See how a strong candidate says it

“I would split the supplied set before tuning, preserve an unseen portion, and ask operations to label acceptable resolutions. I would report the test size and limits rather than extrapolate to every request.”

What a strong candidate could say

Why it works: A held-out set prevents the demonstration from testing memorized examples.

Step 3: Keep the boundary

What would you do here? Open the move you’d make.

  • Test anonymized data under approval

    The strong move. A commercial deadline does not replace access approval.

  • Propose live data for a more realistic trial

    Tempting, but it misses something. The packet explicitly withholds approval for live customer access.

See how a strong candidate says it

“I would use the approved anonymized data and include refund-policy failures in review. Live access requires a separate approval; sales cannot grant it.”

What a strong candidate could say

Why it works: A commercial deadline does not replace access approval.

Step 4: Make the result actionable

What would you do here? Open the move you’d make.

  • Offer an open-ended free pilot

    Tempting, but it misses something. An indefinite pilot creates work without a defined decision.

  • Name the decision owner and date

    The strong move. A test without a decision path can continue without a purchase reason.

See how a strong candidate says it

“Before the trial I would name who can accept the result, book a decision meeting, and agree what leads to a paid next step, another bounded test, or a stop.”

What a strong candidate could say

Why it works: A test without a decision path can continue without a purchase reason.

The answer, in short

Decision
Run a bounded proof with buyer-approved acceptance and a decision date.
Because
The buyer needs evidence on its own work, including review and policy failures.
What would change it
A buyer-approved change in the use case or unacceptable failure would change the test.

Common traps

  • Reporting training examples as validation.
  • Promising live access or a guaranteed uplift.

Check your answer

  • Is the acceptance measure approved by support and finance?
  • Is some evidence held out before tuning?
  • Does the trial respect the approved data boundary?
  • Are the decision owner, date and stop rule explicit?

Last reviewed Nov 10, 2026